Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

被引：0
|
作者：
Lo Nigro, Luca [1 ]
机构：
[1] Azienda Policlin G Rodol San Marco, Ctr Pediat Hematol Oncol, Head Cytogenet Cytofluorimetr Mol Biol Lab, Catania, Italy
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
mTOR - mammalian target of rapamycin; acute leukemias; PTEN (phosphatase and tensin homolog deleted on chromosome 10); Rapalogs; PI3; K/AKT;
D O I：
10.3389/fonc.2023.1293795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Targeting the process of farynesylation for therapy of hematologic malignancies
    Karp, JE
    Lancet, JE
    CURRENT MOLECULAR MEDICINE, 2005, 5 (07) : 643 - 652
  • [32] Targeting BCL-2 in Hematologic Malignancies
    Khan, Nadia
    Kahl, Brad
    TARGETED ONCOLOGY, 2018, 13 (03) : 257 - 267
  • [33] Targeting NF-κB in hematologic malignancies
    T Braun
    G Carvalho
    C Fabre
    J Grosjean
    P Fenaux
    G Kroemer
    Cell Death & Differentiation, 2006, 13 : 748 - 758
  • [34] Targeting of Ubiquitin Ligases for the Treatment of Hematologic Malignancies
    Ebert, B. Levine
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 27 - 27
  • [35] Targeting BCL-2 in Hematologic Malignancies
    Nadia Khan
    Brad Kahl
    Targeted Oncology, 2018, 13 : 257 - 267
  • [36] TARGETING UBIQUITIN LIGASES FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES
    Ebert, Benjamin
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (08) : S10 - S10
  • [37] Targeting oncogenic Ras signaling in hematologic malignancies
    Ward, Ashley F.
    Braun, Benjamin S.
    Shannon, Kevin M.
    BLOOD, 2012, 120 (17) : 3397 - 3406
  • [38] Targeting the integrated stress response in hematologic malignancies
    Gus O. Nwosu
    Jason A. Powell
    Stuart M. Pitson
    Experimental Hematology & Oncology, 11
  • [39] Targeting NF-κB in hematologic malignancies
    Braun, T
    Carvalho, G
    Fabre, C
    Grosjean, J
    Fenaux, P
    Kroemer, G
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (05): : 748 - 758
  • [40] Therapeutic Targeting of the Sphingolipid "Biostat" in Hematologic Malignancies
    Loughran, Thomas P., Jr.
    Wang, Hong-Gang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (09) : 780 - 781
12345